首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備呼吸器

市場調查報告書

商品編碼

1738616

霧化器市場規模（按產品類型、行動性別、最終用戶、區域範圍和預測）

Nebulizers Market Size By Product Type (Pneumatic Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers), By Portability (Tabletop Nebulizers, Portable Nebulizers), By End-user (Hospitals, Clinics, Home Healthcare), By Geographic Scope And Forecast

出版日期: 2025年05月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

霧化器市場規模及預測

2024 年霧化器市場規模價值為 11.1218 億美元，預計到 2032 年將達到 17.583 億美元，2026 年至 2032 年的複合年成長率為 6.50%。

霧化器是醫療設備，用於將藥物以霧狀吸入肺部。

這些設備用於治療氣喘、慢性阻塞性肺病(COPD)、囊腫纖維化和其他肺部疾病等呼吸系統疾病。

此外，霧化器也用於將多種藥物（包括支氣管擴張劑、皮質類固醇和抗生素）直接輸送到呼吸系統。

霧化器市場動態

影響霧化器市場的關鍵市場動態是：

關鍵市場促進因素

呼吸系統疾病盛行率不斷上升：氣喘、慢性阻塞性肺病(COPD) 和囊腫纖維化等慢性呼吸道疾病盛行率不斷上升，是霧化器產業發展的關鍵驅動力。根據世界衛生組織 (WHO) 的數據，全球有超過 2.62 億人患有氣喘，其中很大一部分患者需要霧化器等吸入療法才能成功治療。這些呼吸系統疾病盛行率的不斷上升，推動了對霧化器作為可靠治療方案的需求。

老年人口不斷成長：老年人口的成長更容易患呼吸系統疾病，這推動了霧化器的使用。根據聯合國世界人口老化研究報告，預計到2050年，全球65歲及以上人口將增加四倍，這將增加對呼吸照護解決方案的需求。老年患者通常難以使用標準吸入器，因此霧化器成為重要的藥物傳遞選擇，尤其對於那些手呼吸協調性較差的患者而言。

空氣污染加劇引發呼吸系統疾病：空氣污染水平的上升導致呼吸系統健康問題激增，進一步刺激了對霧化器的需求。根據世界衛生組織 (WHO) 的數據，全球 99% 的人口呼吸的空氣品質超過 WHO 的指南值，導致氣喘和慢性阻塞性肺病 (COPD) 等呼吸系統併發症。機會污染空氣的增加導致霧化器用於治療這些疾病的使用增加，尤其是在污染嚴重的都市區。

主要問題

先進霧化器高成本：更新、更先進的霧化器技術的成本被認為是採用該技術的潛在障礙，特別是在發展中地區和經濟困難的患者。

替代設備的可用性：霧化器市場面臨來自替代呼吸藥物輸送設備（如吸入器）的競爭，這些設備通常被認為對某些病患小組更方便，這可能會限制霧化器市場的成長。

主要趨勢

智慧霧化器：我們看到智慧技術融入霧化器設備，其內建劑量追蹤、治療提醒和與行動醫療應用程式連接等功能可提高治療依從性和患者治療效果。

環保設計：隨著對環境永續醫療保健解決方案的日益關注，霧化器製造商正在尋求環保材料和設計，以減少其產品對環境的影響。

客製化和個人化：我們正在努力開發適合個別患者需求的霧化器，包括調整流速、粒度和劑量，以針對不同症狀和患者情況最佳化治療效果。

霧化器市場區域分析

北美洲

根據 Verified Market Research 的調查，預計北美將在預測期內主導霧化器市場。美國地區氣喘(COPD) 和囊腫纖維化等呼吸系統疾病患者人數眾多，推動了霧化器的需求。根據美國疾病管制與預防中心 (CDC) 的數據，約有 2,500 萬美國患有氣喘，超過 1,600 萬人被診斷出患有 COPD。如此高的疾病負擔增加了霧化器作為有效進行呼吸治療的必備設備的需求。

北美老齡人口的成長也推動了霧化器需求的成長。根據美國人口普查局的數據，預計到2034年，美國65歲以上人口將達到7,700萬，歷史上首次超過兒童人口。隨著呼吸系統疾病在老年人群中日益普遍，霧化器正成為老年族群管理這些症狀的重要工具。

此外，空氣污染已成為北美的健康問題，有害污染物導致呼吸系統疾病增加。美國環保署 (EPA) 報告稱，數百萬美國人生活在空氣污染超標的地區，導致氣喘(COPD) 等呼吸系統疾病激增。接觸污染物的增加增加了對霧化器的需求，以幫助控制這些症狀，尤其是在空氣品質較差的地區。

亞太地區

預計在預測期內，亞太地區霧化器市場將呈現最高成長。亞太地區氣喘和慢性阻塞性肺病(COPD) 等呼吸系統疾病的發生率顯著上升。根據《2018 年全球氣喘報告》，亞太地區約有 1.75 億人患有氣喘，其中許多人需要霧化器治療才能有效控制病情。此類呼吸系統疾病的高發生率正推動全部區域霧化器的普及率不斷提高。

亞太地區多個國家正在改善和擴大醫療基礎設施，以促進包括霧化器在內的醫療設備的普及。世界銀行的數據顯示，印度和中國等國家已優先投資醫療基礎設施，從而提高了呼吸系統疾病的可近性。醫院和診所霧化器供應量的不斷成長，也支撐了對有效吸入療法日益成長的需求。

此外，亞太地區主要城市的空氣污染水平不斷上升，導致呼吸系統疾病激增，進一步增加了對霧化器的需求。世界衛生組織 (WHO) 報告稱，許多亞太國家的空氣品質遠低於建議標準，導致呼吸系統疾病增加。隨著越來越多的人尋求治療與污染相關的呼吸系統疾病，預計該地區對霧化器的需求將會成長。

霧化器市場細分分析

霧化器市場根據產品類型、便攜性、最終用戶和地區進行細分。

霧化器市場（依產品類型）

氣動霧化器
超音波霧化器
篩孔式噴霧器

根據產品類型，市場細分為氣動霧化器、超音波霧化器和篩孔式噴霧器。篩孔式噴霧器憑藉其緊湊的設計、便攜性和高效的藥物輸送，預計將佔據霧化器市場的主導地位。篩孔式噴霧器利用振動網格將藥物霧化，從而縮短治療時間並提高顆粒尺寸，從而更好地將藥物輸送至肺部。這使得它們特別適合需要有效吸入治療的嚴重呼吸系統疾病患者。技術進步進一步提高了篩孔式噴霧器的性能和可靠性，使其在醫療保健提供者和患者中更受歡迎。

霧化器市場，移動比例

桌上型霧化器
攜帶式霧化器

根據便攜性，霧化器市場可細分為桌上型霧化器和攜帶式霧化器。攜帶式霧化器預計將佔據霧化器市場的主導地位，因為它能夠適應現代生活方式，並滿足日益成長的家庭醫療保健解決方案需求。攜帶式霧化器的設計充分考慮了便利性，使患者能夠隨時隨地快速有效地接受治療。這項特點對於患有氣喘和慢性阻塞性肺病(COPD) 等需要頻繁或持續吸入治療的患者尤其具有吸引力。慢性呼吸系統疾病的增加進一步推動了攜帶式霧化器市場的成長，因為越來越多的患者尋求能夠無縫融入日常生活的便利治療方案。攜帶式霧化器小巧輕便的設計使其易於攜帶，提高了包括兒科和老年患者在內的各類患者群體的可用性。隨著醫療保健模式不斷轉向以患者為中心的模式，這些設備的便攜性在臨床環境之外的呼吸系統疾病管理中具有顯著優勢。

霧化器市場（按最終用戶分類）

醫院
診所
家庭醫療保健

根據最終用戶，市場細分為醫院、診所和家庭醫療保健。由於家庭醫療保健的便利性和易用性，預計在估計和預測期內將佔據市場主導地位。攜帶式霧化器專為行動治療而設計，使患者能夠有效地管理呼吸系統疾病，而無需局限於特定位置。這項特點對於生活繁忙和經常旅行的人尤其有益。家庭醫療保健的趨勢也大大促進了攜帶式霧化器需求的成長。隨著患者越來越傾向於在家中而不是在臨床環境中接受治療，攜帶式霧化器的緊湊設計和輕巧特性使其成為頗具吸引力的選擇。

霧化器市場（按地區）

北美洲
歐洲
亞太地區
其他

根據地區，霧化器市場分為北美、歐洲、亞太地區和世界其他地區。由於呼吸系統疾病高發生率、醫療舉措等多種因素，預計北美將在預測期內佔據主導地位。大量患有氣喘和慢性阻塞性肺病(COPD) 等疾病的患者正在推動該地區對有效霧化器治療的需求。北美擁有完善的醫療保健體系，霧化器廣泛應用於醫院、診所和居家醫療等各種醫療場所。領先製造商的存在和霧化器技術的持續創新進一步加強了市場格局，使設備更加有效、方便用戶使用。這些進步還包括攜帶式和電池供電的霧化器的開發，以滿足需要隨時隨地接受治療的患者的需求。

主要參與企業

霧化器市場研究報告提供了聚焦全球市場的寶貴見解。市場主要企業包括荷蘭皇家飛利浦公司 (Koninklijke Philips NV)、歐姆龍公司 (OMRON Corporation)、PARI GmbH、Allied Healthcare Products, Inc.、Becton, Dickinson and Company、Briggs Healthcare、DeVilbiss Healthcare LLC、Gerber Electrical Co.、Medtronic plc 和 GF Health Products plc。

我們的市場分析還包含一個關於這些主要企業的專門章節，我們的分析師將在其中提供所有主要企業財務報表的深入分析，以及產品基準化分析和 SWOT 分析。競爭格局部分還包括對上述參與企業的關鍵發展策略、市場佔有率和全球市場排名的分析。

霧化器市場的最新趨勢
2022年2月，領先的醫療設備製造商歐姆龍醫療宣佈在歐洲推出其新型網狀霧化器－歐姆龍Microair U100。該設備旨在更有效率地進行氣霧治療，尤其適用於氣喘和慢性阻塞性肺病患者。這項技術創新鞏固了歐姆龍在歐洲霧化器市場的地位，為用戶提供便攜、安靜且高效的霧化器。
2021年8月，全球領先的呼吸照護解決方案供應商PARI Pharma宣布與德國肺臟研究中心合作，進行其先進霧化器系統的臨床試驗。這些臨床試驗旨在評估PARI霧化器在囊腫纖維化等呼吸系統疾病精準治療的有效性。此次合作將支援新型霧化器技術的開發，進一步活化歐洲市場。

Increasing Prevalence of Respiratory Disorders: The increased prevalence of chronic respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, is a significant driver of the nebulizer industry. According to the World Health Organization (WHO), over 262 million people worldwide suffer from asthma, with a large proportion requiring inhalation therapies, such as nebulizers, for successful treatment. The increased prevalence of these respiratory disorders increases the need for nebulizers as a dependable therapy option.

Rising Geriatric Population: The expanding older population, which is more susceptible to respiratory problems, is boosting the use of nebulizers. According to the United Nations' World Population Aging study, the global population of 65 and older is predicted to quadruple by 2050, boosting the demand for respiratory care solutions. Older patients frequently have difficulty using standard inhalers, making nebulizers a vital choice for drug delivery, particularly for individuals with reduced hand-breath coordination.

Increasing Air Pollution Leading to Respiratory Issues: The rise in air pollution levels has led to a surge in respiratory health problems, further boosting the demand for nebulizers. The World Health Organization (WHO) states that 99% of the world population breathes air that exceeds WHO guideline limits, leading to respiratory complications like asthma and COPD. The increasing exposure to polluted air has contributed to the growing use of nebulizers to treat these conditions, particularly in urban areas with higher pollution levels.

Key Challenges:

High Cost of Advanced Nebulizers: The expense associated with newer, more advanced nebulizer technologies is noted as a potential barrier to adoption, particularly in developing regions or for patients with limited financial resources.

Availability of Alternative Devices: Competition from alternative respiratory drug delivery devices, such as inhalers, is faced by the nebulizer market. These alternatives are often perceived as more convenient for certain patient groups, potentially limiting nebulizer market growth.

Key Trends:

Smart Nebulizers: The integration of smart technologies into nebulizer devices is observed. Features such as dose tracking, treatment reminders, and connectivity with mobile health apps are incorporated to improve treatment adherence and patient outcomes.

Eco-friendly Designs: A growing focus on environmentally sustainable healthcare solutions is noted. Nebulizer manufacturers are exploring eco-friendly materials and designs to reduce the environmental impact of their products.

Customization and Personalization: Efforts to develop nebulizers that are tailored to individual patient needs are made. This includes adjustable flow rates, particle sizes, and medication dosages to optimize treatment efficacy for different conditions and patient profiles.

Nebulizers Market Regional Analysis

The regional analysis of the nebulizers market:

North America:

According to Verified Market Research, North America is estimated to dominate the nebulizers market over the forecast period. The North American region has a significant number of people suffering from respiratory conditions such as asthma, COPD, and cystic fibrosis, which drive the demand for nebulizers. According to the Centers for Disease Control and Prevention (CDC), approximately 25 million Americans have asthma, and over 16 million people have been diagnosed with COPD. This high disease burden leads to an increasing need for nebulizers as an essential device for delivering respiratory therapies effectively.

The growing elderly population in North America contributes to the increasing demand for nebulizers. According to the U.S. Census Bureau, the number of people aged 65 and older in the United States is expected to reach 77 million by 2034, surpassing the number of children for the first time in history. As respiratory diseases become more prevalent among older adults, nebulizers are becoming a crucial tool for managing these conditions in this demographic.

Furthermore, air pollution is a growing health concern in North America, with harmful pollutants contributing to the rise of respiratory diseases. The Environmental Protection Agency (EPA) reported that millions of Americans live in regions where air pollution exceeds safe levels, leading to a spike in respiratory illnesses like asthma and COPD. The increased exposure to pollutants is driving the need for nebulizers, particularly in areas with poor air quality, to assist in managing these conditions.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth in the nebulizers market during the forecast period. The Asia-Pacific region is witnessing a significant rise in respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). According to the Global Asthma Report 2018, around 175 million people are affected by asthma in the Asia-Pacific, with many requiring nebulization therapy for effective management. This high prevalence of respiratory diseases is driving the increased adoption of nebulizers across the region.

The improvement and expansion of healthcare infrastructure in several Asia-Pacific countries are facilitating better access to medical devices, including nebulizers. According to the World Bank, investments in healthcare infrastructure have been prioritized in nations like India and China, leading to enhanced accessibility to respiratory treatments. The growing availability of nebulizers in hospitals and clinics supports the rising demand for effective inhalation therapies.

Furthermore, rising air pollution levels in major cities across the Asia-Pacific region have led to a surge in respiratory illnesses, further propelling the need for nebulizers. The World Health Organization (WHO) has reported that air quality in many Asia-Pacific countries is significantly below recommended standards, contributing to respiratory problems. As more individuals seek treatment for pollution-related respiratory issues, the demand for nebulizers is expected to grow in this region.

Nebulizers Market: Segmentation Analysis

The Nebulizers Market is segmented based on Product Type, Portability, End-user, and Geography.

Nebulizers Market, By Product Type

Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers

Based on Product Type, the market is segmented into Pneumatic Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers. The mesh nebulizers segment is estimated to dominate the nebulizers market due to its compact design, portability, and efficiency in delivering medication. Mesh nebulizers utilize a vibrating mesh to aerosolize medication, allowing for faster treatment times and finer particle sizes that enhance drug delivery to the lungs. This makes them particularly suitable for patients with severe respiratory conditions who require effective inhalation therapies. Technological advancements have further improved the performance and reliability of mesh nebulizers, contributing to their growing popularity among healthcare providers and patients alike.

Nebulizers Market, By Portability

Tabletop Nebulizers
Portable Nebulizers

Based on Portability, the market is segmented into Tabletop Nebulizers and Portable Nebulizers. The portable nebulizers segment is estimated to dominate the nebulizers market due to its adaptability to modern lifestyles and the increasing demand for at-home healthcare solutions. Portable nebulizers are designed for convenience, allowing patients to administer treatments quickly and efficiently while on the go. This feature is particularly appealing to individuals who require frequent or continuous inhalation therapy for conditions such as asthma or chronic obstructive pulmonary disease (COPD). The rise in chronic respiratory diseases has further propelled the growth of the portable nebulizer segment, as more patients seek accessible treatment options that fit seamlessly into their daily routines. The compact and lightweight design of portable nebulizers makes them easy to carry, enhancing their usability for various patient demographics, including children and the elderly. As healthcare continues to shift toward patient-centric models, the portability of these devices offers significant advantages in managing respiratory conditions outside of clinical settings.

Nebulizers Market, By End-user

Hospitals
Clinics
Home Healthcare

Based on End-user, the market is segmented into Hospitals, Clinics, and Home Healthcare. The home healthcare segment is estimated to dominate the market over the forecast period due to its convenience and ease of use. Portable nebulizers are designed for on-the-go treatment, allowing patients to manage their respiratory conditions effectively without being confined to a specific location. This feature is especially beneficial for individuals with busy lifestyles or those who frequently travel. The growing trend toward home healthcare has also significantly contributed to the rising demand for portable nebulizers. As patients increasingly prefer to receive treatments at home rather than in clinical settings, the compact design and lightweight nature of portable nebulizers make them an attractive option.

Nebulizers Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the nebulizers market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to dominate during the forecast period due to a combination of factors, including a high prevalence of respiratory diseases, advanced healthcare infrastructure, and strong government support for healthcare initiatives. The significant number of patients suffering from conditions such as asthma and chronic obstructive pulmonary disease (COPD) drives the demand for effective nebulization therapies in this region. North America boasts a well-established healthcare system, which ensures the widespread availability of nebulizers across various healthcare settings, including hospitals, clinics, and home healthcare. The presence of leading manufacturers and ongoing innovations in nebulizer technology further enhance the market landscape, allowing for more effective and user-friendly devices. These advancements include the development of portable and battery-operated nebulizers, catering to the needs of patients who require treatment on the go.

Key Players

The "Nebulizers Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Koninklijke Philips N.V., OMRON Corporation, PARI GmbH, Allied Healthcare Products, Inc., Becton, Dickinson and Company, Briggs Healthcare, DeVilbiss Healthcare LLC, Gerber Electrical Co., Medtronic plc, and GF Health Products, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Nebulizers Market Recent Developments
In February 2022, Omron Healthcare, a leading medical device manufacturer, announced the launch of its new mesh nebulizer, the Omron MicroAir U100, in Europe. The device is designed to deliver aerosol treatments more efficiently, particularly for asthma and COPD patients. This innovation has strengthened Omron's position in the European nebulizer market by offering portable, silent, and highly efficient nebulization.
In August 2021, PARI Pharma, a global leader in respiratory care solutions, announced a collaboration with the German Center for Lung Research to conduct clinical trials on advanced nebulizer systems. These trials aim to assess the effectiveness of PARI's nebulizers in delivering precision therapies for respiratory conditions like cystic fibrosis. The collaboration supports the development of new nebulizer technologies, further boosting the market in Europe.

1 INTRODUCTION OF GLOBAL NEBULIZERS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBALNEBULIZERS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 Nebulizers Market, By Product Type

5.1 Overview
5.2 Pneumatic Nebulizers
5.3 Ultrasonic Nebulizers
5.4 Mesh Nebulizers

6 Nebulizers Market, By Portability

6.1 Overview
6.2 Tabletop Nebulizers
6.3 Portable Nebulizers

7 GLOBAL NEBULIZERS MARKET, BY END-USE

7.1 Overview
7.2 Hospitals
7.3 Clinics
7.4 Home Healthcare

8 GLOBAL NEBULIZERS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL NEBULIZERS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Koninklijke Philips N.V.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 OMRON Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 PARI GmbH
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Allied Healthcare Products, Inc.
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Becton
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Dickinson and Company
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Briggs Healthcare
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 DeVilbiss Healthcare LLC
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 erber Electrical Co.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Medtronic plc
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 GF Health Products, Inc.
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments